Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): “Real World” Experience
Dimitra Rafailia Bakaloudi, Rafee Talukder, Genevieve Ihsiu Lin, Dimitrios Makrakis, Leonidas Nikolaos Diamantopoulos, Nishita Tripathi, Neeraj Agarwal, Roubini Zakopoulou, Aristotelis Bamias, Jason R. Brown, David J. Pinato, James Korolewicz, Tanya Jindal, Vadim S. Koshkin, Jure Murgić, Marija Miletić, Ana Fröbe, Jeffrey S. Johnson, Yousef Zakharia, Alexandra Drakaki, Alejo Rodríguez‐Vida, Macarena Rey-Cárdenas, Daniel Castellano, Lucía Alonso Buznego, Ignacio Durán, Clara Castro Carballeira, Rafael Morales‐Barrera, David Marmorejo, Rana R. McKay, Tyler F. Stewart, Shilpa Gupta, Andrew Ruplin, Evan Y. Yu, Ali Raza Khaki, Petros Grivas
Topics & Concepts
MedicineAvelumabUrothelial carcinomaOncologyChemotherapyInternal medicineMetastatic Urothelial CarcinomaCarcinomaAdrenocortical carcinomaBladder cancerImmunotherapyCancerNivolumabBladder and Urothelial Cancer TreatmentsRenal cell carcinoma treatmentFerroptosis and cancer prognosis